Clinical Trial Update: Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 pediatric trial evaluating bosutinib for Philadelphia chromosome-positive chronic myeloid leukemia in children, including newly diagnosed c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• BOSULIF (bosutinib)

Snippet

Sponsor: Children's Oncology Group | Conditions: Philadelphia Chromosome Positive CML, Accelerated Phase Chronic Myelogenous Leukemia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING